USPTO serial 97231262
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: 27 Oct 2026
The USPTO requires you to have a U.S.-licensed attorney represent your application because your previous representative's information was removed, and the search for conflicting marks has been temporarily deferred.
New Gene (Hangzhou) Bioengineering Co., Ltd.
Hangzhou, Zhejiang,, CN
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Disinfectants; Biological tissue cultures for medical purposes; Diagnostic preparations for medical purposes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Injectable dermal fillers; Mixed biological preparations for the prevention and treatment of infectious diseases; Opium alkaloid preparations; Prescription synthetic narcotics; Reagent paper for medical purposes | ACTIVE | Dec 1, 2021 |
| Date | Code | Event |
|---|---|---|
| Aug 27, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jul 27, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 27, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Jul 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jul 20, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jul 7, 2023 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED |
| Jul 7, 2023 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Jan 26, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 25, 2022 | NWAP | NEW APPLICATION ENTERED |